|1.||Caballero, M D: 5 articles (04/2005 - 02/2001)|
|2.||Arranz, R: 5 articles (04/2005 - 02/2001)|
|3.||Lahuerta, J J: 5 articles (04/2005 - 02/2001)|
|4.||Conde, E: 5 articles (04/2005 - 02/2001)|
|5.||Sureda, A: 4 articles (04/2005 - 01/2003)|
|6.||Marín, J: 4 articles (04/2005 - 02/2001)|
|7.||Sierra, J: 4 articles (04/2005 - 02/2001)|
|8.||García-Laraña, J: 4 articles (04/2005 - 02/2001)|
|9.||Carreras, E: 4 articles (04/2005 - 01/2003)|
|10.||Gandarillas, M: 4 articles (10/2004 - 02/2001)|
|1.||Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell)
01/01/2003 - "The purpose of this study was to analyse the results and prognostic factors influencing overall survival (OS) and disease-free survival (DFS) in 452 patients diagnosed with diffuse large cell lymphomas (DLCL) treated with high-dose therapy (HDT) included in the Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea (GEL-TAMO) Spanish registry. "
01/01/2003 - "High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative Group."
02/01/2001 - "We investigated the impact of the most commonly used preparative regimens on the outcome of 395 patients with diffuse large cell lymphoma (DLCL), consecutively reported to the registry of the Spanish GEL/TAMO. "
10/01/2004 - "Here we evaluate the results of high-dose chemotherapy and autologous stem-cell transplantation (HDC/ASCT) in 114 patients included in the GEL/TAMO registry between January 1990 and December 1999 with diffuse large B-cell lymphoma who failed to achieve complete remission (CR) with front-line conventional chemotherapy. "
|2.||Hodgkin Disease (Hodgkin's Disease)
08/01/1997 - "Autologous stem cell transplantation for poor prognosis Hodgkin's disease in first complete remission: a retrospective study from the Spanish GEL-TAMO cooperative group."
04/01/2005 - "To analyse outcome and prognostic factors for overall survival (OS) and time to treatment failure (TTF) in 357 patients with Hodgkin's lymphoma (HL) undergoing an autologous stem cell transplantation (ASCT) after a first relapse and reported to the The Grupo Espanol de Linfomas/Trasplante Autologo de Medula Osea (GEL/TAMO) Cooperative Group. "
|3.||Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
02/01/2012 - "Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Español de Linfomas/Trasplante de Médula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation."
09/01/1993 - "Frozen vs. nonfrozen bone marrow for autologous transplantation in lymphomas: a report from the Spanish GEL/TAMO Cooperative Group."
|5.||B-Cell Lymphoma (Lymphoma, B Cell)
|1.||Stem Cell Transplantation
|2.||Drug Therapy (Chemotherapy)
|3.||Transplantation (Transplant Recipients)